ROZLYTREK® is an oral, nonchemotherapy treatment that was granted a breakthrough therapy designation by the FDA.

Image does not depict actual patient.
FDA=Food and Drug Administration; NTRK=neurotrophic tyrosine receptor kinase.

Talking with your doctor

Discover a list of tips to get the conversation started.

Financial Resources

Financial support and resources

Learn about financial resources available to help you access ROZLYTREK.